June 14, 2022 11:34 AM EDT

Covid-19 roundup: European governments push to renegotiate vaccine contracts — report; As PhII data disappoint, PureTech pulls long Covid program

Amber Tong

Before the first Covid-19 vaccines became available, countries scrambled to secure access to the shots, clamoring for supply deals. But as supply now far outstrips …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Covid-19 roundup: European governments push to renegotiate vaccine contracts — report; As PhII data disappoint, PureTech pulls long Covid program

Amber Tong

Sign up to read this article for free.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA

Biopharma begins to contemplate an RFK Jr.-influenced FDA if Trump wins

Pfizer shares new details on obesity pipeline, hints at ‘other opportunities’

GSK buys autoimmune T cell engager for $300M upfront from Chimagen

Novartis takes $800M MorphoSys writedown mere months after closing acquisition

Novartis highlights overall M&A track record following MorphoSys impairment

Following March inspection, Novo Nordisk's semaglutide manufacturing facility cited by FDA

Covid-19 roundup: Eu­ro­pean gov­ern­ments push to rene­go­ti­ate vac­cine con­tracts — re­port; As PhII da­ta dis­ap­point, PureTech pulls long Covid pro­gram

Sign up to read this article for free.

more like this

Viridian Therapeutics

Waltham, MA, USA

Covid-19 roundup: European governments push to renegotiate vaccine contracts — report; As PhII data disappoint, PureTech pulls long Covid program